对补偿性环素D2反应的能力使得在犬类粘膜黑色素瘤中产生了对特拉美丁尼布的耐药性

Bih-Rong Wei1, Vincenzo Verdi1, Shuling Zhang1

  • 1Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

概括

粘膜黑色素瘤细胞可以通过从cyclin D1切换到cyclin D2来抵抗MEK抑制剂,促进增殖. 恢复cyclin D2水平重新使细胞对特拉美替尼治疗具有抗药性.